Found: 6
Select item for more details and to access through your institution.
Therapy of mRCC beyond mTOR-inhibition in clinical practice: results of a retrospective analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 5, p. 823, doi. 10.1007/s00432-014-1610-x
- By:
- Publication type:
- Article
A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 7/8, p. 333, doi. 10.1159/000508450
- By:
- Publication type:
- Article
Initial experience with 18F-fluoroethylcholine PET/CT in staging and monitoring therapy response of advanced renal cell carcinoma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Initial experience with <sup>18</sup>F-fluoroethylcholine PET/CT in staging and monitoring therapy response of advanced renal cell carcinoma.
- Published in:
- Annals of Nuclear Medicine, 2010, v. 24, n. 6, p. 441, doi. 10.1007/s12149-010-0375-9
- By:
- Publication type:
- Article
Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1097, doi. 10.1007/s00280-008-0835-2
- By:
- Publication type:
- Article
Feasibility of sequential use of sunitinib and temsirolimus in advanced renal cell carcinoma.
- Published in:
- 2010
- By:
- Publication type:
- journal article